May 2023
1. SINHA SS, Katz JN, Morrow DA
   Cultivating the Research Landscape for Critical Care Cardiology: The Case for Registry-Based Randomized Controlled Trials.
   Circulation. 2023;147:1637-1639.
   

   >> Share

   
   
2. JEROME GJ, Boyer WR, Bustamante EE, Kariuki J, et al
   Increasing Equity of Physical Activity Promotion for Optimal Cardiovascular Health in Adults: A Scientific Statement From the American Heart Association.
   Circulation. 2023 May 24. doi: 10.1161/CIR.0000000000001148.
   

   >> Share

   
   
3. DALZELL JR
   Issues With the Design of Randomized Trials of Temporary Mechanical Circulatory Support for Cardiogenic Shock.
   Circulation. 2023;147:1489-1491.
   

   >> Share

   
   
4. ZHANG Y, Dron JS, Bellows BK, Khera AV, et al
   Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease.
   Circulation. 2023;147:1556-1559.
   

   >> Share

   
   
5. DAMLUJI AA, Alfaraidhy M, AlHajri N, Rohant NN, et al
   Sarcopenia and Cardiovascular Diseases.
   Circulation. 2023;147:1534-1553.
   

   >> Share

   
   
6. KWAN TW, Wong SS, Hong Y, Kanaya AM, et al
   Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.
   Circulation. 2023 May 8. doi: 10.1161/CIR.0000000000001145.
   

   >> Share

   
   
7. SATTAR N, McMurray J, Boren J, Rawshani A, et al
   Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
   Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.063374.
   

   >> Share

   
   April 2023
8. GIBSON WO, McEvoy JW
   Letter by Gibson and McEvoy Regarding Article, "Influence of Age on the Diagnosis of Myocardial Infarction".
   Circulation. 2023;147:1312-1313.
   

   >> Share

   
   
9. LOWRY MTH, Mills NL, Anand A
   Response by Lowry et al to Letter Regarding Article, "Influence of Age on the Diagnosis of Myocardial Infarction".
   Circulation. 2023;147:1315-1316.
   

   >> Share

   
   
10. CHEN T, Xu X, Zhu H
    Letter by Chen et al Regarding Article, "Influence of Age on the Diagnosis of Myocardial Infarction".
    Circulation. 2023;147:1314.
    

    >> Share

    
    
11. SAMAD Z, Hanif B
    Cardiovascular Diseases in Pakistan: Imagining a Postpandemic, Postconflict Future.
    Circulation. 2023;147:1261-1263.
    

    >> Share

    
    
12. EZAD SM, Ryan M, Donker DW, Pappalardo F, et al
    Unloading the Left Ventricle in Venoarterial ECMO: In Whom, When, and How?
    Circulation. 2023;147:1237-1250.
    

    >> Share

    
    
13. O'DONOGHUE ML, Giugliano RP, Sabatine MS
    Response by O'Donoghue et al to Letter Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
    Circulation. 2023;147:1258-1259.
    

    >> Share

    
    
14. ZHOU X, Sun P, Yang Q
    Letter by Zhou et al Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease".
    Circulation. 2023;147:1256-1257.
    

    >> Share

    
    
15. PARLOW S, Di Santo P, Abdel-Razek O, Jung RG, et al
    Utility of a Smartphone Application in Assessing Palmar Circulation Before Radial Artery Harvesting for Coronary Artery Bypass Grafting.
    Circulation. 2023;147:1183-1185.
    

    >> Share

    
    
16. MA H, Wang X, Xue Q, Li X, et al
    Cardiovascular Health and Life Expectancy Among Adults in the United States.
    Circulation. 2023;147:1137-1146.
    

    >> Share

    
    
17. MEHTA LS, Velarde GP, Lewey J, Sharma G, et al
    Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Apr 10. doi: 10.1161/CIR.0000000000001139.
    

    >> Share

    
    
18. AKL E, Sniderman AD
    Cholesterol, Coronary Calcification, and Cardiovascular Prevention: Lessons We Can Learn From the Western Denmark Heart Registry.
    Circulation. 2023;147:1064-1066.
    

    >> Share

    
    
19. PEREZ DE ISLA L, Diaz-Diaz JL, Romero MJ, Muniz-Grijalvo O, et al
    Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
    Circulation. 2023 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.062557.
    

    >> Share

    
    March 2023
20. CAI W, Liu L, Shi X, Liu Y, et al
    Alox15/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis.
    Circulation. 2023 Mar 29. doi: 10.1161/CIRCULATIONAHA.122.060257.
    

    >> Share

    
    
21. SIPILA PN, Lindbohm JV, David Batty G, Heikkila N, et al
    Severe Infection and Risk of Cardiovascular Disease: A Multicohort Study.
    Circulation. 2023 Mar 27. doi: 10.1161/CIRCULATIONAHA.122.061183.
    

    >> Share

    
    
22. DAVENPORT MS, Perazella MA, Nallamothu BK
    Contrast-Induced Acute Kidney Injury and Cardiovascular Imaging: Danger or Distraction?
    Circulation. 2023;147:847-849.
    

    >> Share

    
    
23. 
    Expression of Concern: c-Cbl Inhibition Improves Cardiac Function and Survival in Response to Myocardial Ischemia.
    Circulation. 2023 Mar 13. doi: 10.1161/CIR.0000000000001144.
    

    >> Share

    
    
24. MENG Z, Zhang Z, Zhao J, Liu C, et al
    Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in Prediabetic Animals.
    Circulation. 2023 Mar 8. doi: 10.1161/CIRCULATIONAHA.122.063073.
    

    >> Share

    
    
25. PARKHOMENKO A
    Russia's War in Ukraine and Cardiovascular Health Care.
    Circulation. 2023;147:779-781.
    

    >> Share

    
    
26. VERMA S, Alamuddin N, Alawadi F, Alkandari H, et al
    Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.
    Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.123.064345.
    

    >> Share

    
    
27. HAN JK, Hwang D, Yang S, Park SH, et al
    Comparison Of 3-6 Month Versus 12 Month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts: The HOST-IDEA Randomized Clinical Trial.
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064264.
    

    >> Share

    
    
28. CAMPBELL DJT, Mitchell C, Hemmelgarn BR, Tonelli M, et al
    Eliminating Medication Copayments for Low-income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial.
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064188.
    

    >> Share

    
    
29. VIRANI SS, Ramsey DJ, Westerman D, Kuebeler MK, et al
    Cluster Randomized Trial Of A Personalized Clinical Decision Support Intervention To Improve Statin Prescribing In Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin).
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064226.
    

    >> Share

    
    
30. MODIN D, Johansen ND, Vaduganathan M, Bhatt AS, et al
    The Effect of Electronic Nudges on Influenza Vaccination Rate in Older Adults With Cardiovascular Disease: a Prespecified Analysis of the NUDGE-FLU Trial.
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064270.
    

    >> Share

    
    
31. CAMPBELL DJT, Tonelli M, Hemmelgarn BR, Faris P, et al
    Self-management Support Using Advertising Principles for Older Low Income Adults at High Cardiovascular Risk: a Randomized Controlled Trial.
    Circulation. 2023 Mar 5. doi: 10.1161/CIRCULATIONAHA.123.064189.
    

    >> Share

    
    
32. YANG J, Shan D, Wang X, Sun X, et al
    On-Site Computed Tomography-Derived Fractional Flow Reserve to Guide the Management of Patients with Stable Coronary Artery Disease: the TARGET Randomized Trial.
    Circulation. 2023 Mar 4. doi: 10.1161/CIRCULATIONAHA.123.063996.
    

    >> Share

    
    February 2023
33. RAZAVI AC, Walden LI, Sperling LS
    Lessons in Cardiovascular Disease Prevention from Number 42: The Told and Untold Stories of Jackie Robinson.
    Circulation. 2023 Feb 28. doi: 10.1161/CIRCULATIONAHA.123.063976.
    

    >> Share

    
    
34. JOSHI PH, Nasir K, Navar AM
    When Opportunity Knocks: Capitalizing on Incidental Coronary Arterial Calcification.
    Circulation. 2023;147:715-717.
    

    >> Share

    
    
35. 
    Correction to: Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women.
    Circulation. 2023;147:e624.
    

    >> Share

    
    
36. GERSTEIN HC, Li Z, Ramasundarahettige C, Baek S, et al
    Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial.
    Circulation. 2023 Feb 20. doi: 10.1161/CIRCULATIONAHA.122.063716.
    

    >> Share

    
    
37. LUU JM, Malhotra P, Cook-Wiens G, Pepine CJ, et al
    Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort.
    Circulation. 2023;147:617-619.
    

    >> Share

    
    
38. COUGHLAN JJ, Raber L, Brugaletta S, Kufner S, et al
    Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation.
    Circulation. 2023;147:575-585.
    

    >> Share

    
    
39. KHAN SS, Brewer LC, Canobbio MM, Cipolla MJ, et al
    Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:e76-e91.
    

    >> Share

    
    
40. BEACH LB, Streed CG Jr
    Beyond Sex-Based Medicine in Cardiovascular Health Research and Practice.
    Circulation. 2023;147:529-531.
    

    >> Share

    
    
41. RODRIGUEZ F
    Sex Disparities in Prevention of Atherosclerotic Cardiovascular Disease Across the Life Course.
    Circulation. 2023;147:523-525.
    

    >> Share

    
    
42. MENG ML, Arendt KW, Banayan JM, Bradley EA, et al
    Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Feb 13. doi: 10.1161/CIR.0000000000001121.
    

    >> Share

    
    
43. GABA P, O'Donoghue ML, Park JG, Wiviott SD, et al
    Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
    Circulation. 2023 Feb 13. doi: 10.1161/CIRCULATIONAHA.122.063399.
    

    >> Share

    
    
44. HENRY TD, Yannopoulos D, van Diepen S
    Extracorporeal Membrane Oxygenation for Cardiogenic Shock: When to Open the Parachute?
    Circulation. 2023;147:465-468.
    

    >> Share

    
    
45. OSTADAL P, Rokyta R, Karasek J, Kruger A, et al
    Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial.
    Circulation. 2023;147:454-464.
    

    >> Share

    
    
46. SHEN M, Liu C, Zhao SR, Manhas A, et al
    Stepwise Generation of Human Induced Pluripotent Stem Cell-Derived Cardiac Pericytes to Model Coronary Microvascular Dysfunction.
    Circulation. 2023;147:515-518.
    

    >> Share

    
    January 2023
47. BULARGA A, Ken Lee K, Shah ASV, Anand A, et al
    Impact of Patient Selection on Performance of an Early Rule-Out Pathway for Myocardial Infarction: From Research to the Real World.
    Circulation. 2023;147:447-449.
    

    >> Share

    
    
48. STUBER M, Baggish AL
    Acute Myocardial Injury in the COVID-HEART Study: Emphasizing Scars While Reassuring Scares.
    Circulation. 2023;147:375-377.
    

    >> Share

    
    
49. DIMOPOULOS K, Constantine A, Clift P, Condliffe R, et al
    Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus.
    Circulation. 2023;147:425-441.
    

    >> Share

    
    
50. VLASSCHAERT C, Heimlich JB, Rauh MJ, Natarajan P, et al
    Interleukin-6 Receptor Polymorphism Attenuates Clonal Hematopoiesis-Mediated Coronary Artery Disease Risk Among 451 180 Individuals in the UK Biobank.
    Circulation. 2023;147:358-360.
    

    >> Share

    
    
51. RIGAUD VOC, Hoy RC, Kurian J, Zarka C, et al
    RNA-Binding Protein LIN28a Regulates New Myocyte Formation in the Heart Through Long Noncoding RNA-H19.
    Circulation. 2023;147:324-337.
    

    >> Share

    
    
52. LAWLER PR
    Models for Evidence Generation During the COVID-19 Pandemic: New Opportunities for Clinical Trials in Cardiovascular Medicine.
    Circulation. 2023;147:187-189.
    

    >> Share

    
    
53. POWELL-WILEY TM
    Centering Patient Voices Through Community Engagement in Cardiovascular Research.
    Circulation. 2023;147:105-107.
    

    >> Share

    
    
54. CAPODANNO D, Angiolillo DJ
    Long-Term P2Y(12) Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention.
    Circulation. 2023;147:118-121.
    

    >> Share

    
    
55. MORTENSEN MB, Dzaye O, Botker HE, Jensen JM, et al
    Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry.
    Circulation. 2023 Jan 9. doi: 10.1161/CIRCULATIONAHA.122.061010.
    

    >> Share

    
    
56. AENGEVAEREN VL, Mosterd A, Bakker EA, Braber TL, et al
    Exercise Volume Versus Intensity and the Progression of Coronary Atherosclerosis in Middle-Aged and Older Athletes: Findings From the MARC-2 Study.
    Circulation. 2023 Jan 4. doi: 10.1161/CIRCULATIONAHA.122.061173.
    

    >> Share

    
    
57. NTSEKHE M, Baker JV
    Cardiovascular Disease Among Persons Living With HIV: New Insights Into Pathogenesis and Clinical Manifestations in a Global Context.
    Circulation. 2023;147:83-100.
    

    >> Share

    
    
58. WESTCOTT SK, Lewis TT, Albert MA
    Tackling Adversity and Cardiovascular Health: It is About Time.
    Circulation. 2023;147:e1-e3.
    

    >> Share

    
    
59. BRADLEY SM, Gluckman TJ
    If the Fates Allow: The Zero-Sum Game of ISCHEMIA-EXTEND.
    Circulation. 2023;147:20-22.
    

    >> Share

    
    December 2022
60. CHENG YY, Gregorich Z, Prajnamitra RP, Lundy DJ, et al
    Metabolic Changes Associated With Cardiomyocyte Dedifferentiation Enable Adult Mammalian Cardiac Regeneration.
    Circulation. 2022;146:1950-1967.
    

    >> Share

    
    
61. PALUCH AE, Bajpai S, Ballin M, Bassett DR, et al
    Prospective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis.
    Circulation. 2022 Dec 20. doi: 10.1161/CIRCULATIONAHA.122.061288.
    

    >> Share

    
    
62. GYLDENKERNE C, Maeng M, Kjoller-Hansen L, Maehara A, et al
    Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061983.
    

    >> Share

    
    
63. MARK ESTES NA, Jain S, Saba S
    Coronary Vasospasm With Pulse Field Ablation: Primum Non Nocere.
    Circulation. 2022;146:1820-1822.
    

    >> Share

    
    
64. MARX N, Husain M, Lehrke M, Verma S, et al
    GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes.
    Circulation. 2022;146:1882-1894.
    

    >> Share

    
    
65. TANI H, Sadahiro T, Yamada Y, Isomi M, et al
    Direct Reprogramming Improves Cardiac Function and Reverses Fibrosis in Chronic Myocardial Infarction.
    Circulation. 2022 Dec 12. doi: 10.1161/CIRCULATIONAHA.121.058655.
    

    >> Share

    
    
66. DAMLUJI AA, Forman DE, Wang TY, Chikwe J, et al
    Management of Acute Coronary Syndrome in the Older Adult Population: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Dec 12. doi: 10.1161/CIR.0000000000001112.
    

    >> Share

    
    
67. ALAHMAD B, Khraishah H, Roye D, Vicedo-Cabrera AM, et al
    Associations Between Extreme Temperatures and Cardiovascular Cause-Specific Mortality: Results From 27 Countries.
    Circulation. 2022 Dec 12. doi: 10.1161/CIRCULATIONAHA.122.061832.
    

    >> Share

    
    
68. MASURKAR N, Bouvet M, Logeart D, Jouve C, et al
    Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction.
    Circulation. 2022 Dec 9. doi: 10.1161/CIRCULATIONAHA.121.056272.
    

    >> Share

    
    
69. 
    Correction to: A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
    Circulation. 2022;146:e330.
    

    >> Share

    
    November 2022
70. FIGTREE GA, Adamson PD, Antoniades C, Blumenthal RS, et al
    Noninvasive Plaque Imaging to Accelerate Coronary Artery Disease Drug Development.
    Circulation. 2022;146:1712-1727.
    

    >> Share

    
    
71. RAITAKARI O, Kartiosuo N, Pahkala K, Hutri-Kahonen N, et al
    Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood.
    Circulation. 2022 Nov 28. doi: 10.1161/CIRCULATIONAHA.122.060667.
    

    >> Share

    
    
72. MOSARLA RC, Secemsky EA
    From IMPERIALism to EMINENence: The Noble Rise of the Second-Generation Peripheral Drug-Eluting Stent.
    Circulation. 2022;146:1577-1580.
    

    >> Share

    
    
73. TONELLI M, Straus S
    Increasing Societal Benefit From Cardiovascular Drugs.
    Circulation. 2022;146:1627-1635.
    

    >> Share

    
    
74. STEG PG, Kikoine J
    Do We Need Ischemia Testing to Monitor Asymptomatic Patients With Chronic Coronary Syndromes?
    Circulation. 2022 Nov 16. doi: 10.1161/CIRCULATIONAHA.122.053565.
    

    >> Share

    
    
75. ZHANG S, Liu S, Leach JP, Li K, et al
    Gene Therapy Knockdown of Hippo Signaling Resolves Arrhythmic Events in Pigs After Myocardial Infarction.
    Circulation. 2022;146:1558-1560.
    

    >> Share

    
    
76. 
    Correction to: Status of Cardiovascular Health in US Adults and Children Using the American Heart Association's New "Life's Essential 8" Metrics: Prevalence Estimates From the National Health and Nutrition Examination Survey (NHANES), 2013 Through 201
    Circulation. 2022;146:e298.
    

    >> Share

    
    
77. TAKAHASHI EA, Schwamm LH, Adeoye OM, Alabi O, et al
    An Overview of Telehealth in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Nov 14. doi: 10.1161/CIR.0000000000001107.
    

    >> Share

    
    
78. AGIRBASLI M, Aksoy A
    Letter by Agirbasli and Aksoy Regarding Article, "Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study".
    Circulation. 2022;146:e257.
    

    >> Share

    
    
79. BULARGA A, Mills NL, Chapman AR
    Response by Bularga et al to Letter Regarding Article, "Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study".
    Circulation. 2022;146:e258-e259.
    

    >> Share

    
    
80. SANDHU AT, Rodriguez F, Ngo S, Patel BN, et al
    Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project).
    Circulation. 2022 Nov 7. doi: 10.1161/CIRCULATIONAHA.122.062746.
    

    >> Share

    
    
81. KANG J, Park KW, Lee H, Hwang D, et al
    Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study.
    Circulation. 2022 Nov 7. doi: 10.1161/CIRCULATIONAHA.122.062770.
    

    >> Share

    
    
82. HOCHMAN JS, Anthopolos R, Reynolds HR, Bangalore S, et al
    Survival After Invasive or Conservative Management of Stable Coronary Disease.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062714.
    

    >> Share

    
    
83. WU H, Xu L, Zhao X, Zhang H, et al
    Indobufen or Aspirin on Top of Clopidogrel after Coronary Drug-eluting Stent Implantation (OPTION): a Randomized, Open-label, Endpoint-blinded, Non-inferiority Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062762.
    

    >> Share

    
    
84. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
    A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
    

    >> Share

    
    
85. SHAH NS, Huang X, Petito LC, Bancks MP, et al
    Social and Psychosocial Determinants of Racial and Ethnic Differences in Cardiovascular Health in the United States Population.
    Circulation. 2022 Nov 5. doi: 10.1161/CIRCULATIONAHA.122.061991.
    

    >> Share

    
    
86. WYCKOFF MH, Greif R, Morley PT, Ng KC, et al
    2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2022 Nov 3. doi: 10.1161/CIR.0000000000001095.
    

    >> Share

    
    
87. MEHRAN R, Steg PG, Pfeffer MA, Jering K, et al
    The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial.
    Circulation. 2022 Nov 2. doi: 10.1161/CIRCULATIONAHA.122.060841.
    

    >> Share

    
    
88. AIRAKSINEN KEJ, Aalto R, Hellman T, Vasankari T, et al
    Novel Troponin Fragmentation Assay to Discriminate Between Troponin Elevations in Acute Myocardial Infarction and End-Stage Renal Disease.
    Circulation. 2022;146:1408-1410.
    

    >> Share

    
    October 2022
89. APPLE FS, Smith SW, Greenslade JH, Sandoval Y, et al
    Single High-Sensitivity Point of Care Whole Blood Cardiac Troponin I Measurement to Rule Out Acute Myocardial Infarction at Low Risk.
    Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.061148.
    

    >> Share

    
    
90. GAZIANO L, Sun L, Arnold M, Bell S, et al
    Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.
    Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.060700.
    

    >> Share

    
    
91. INOUE K, Seeman TE, Horwich T, Budoff MJ, et al
    Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine Learning Approach in the MESA Study.
    Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.062626.
    

    >> Share

    
    
92. RUEL M, Williams A
    A New Effect Modifier of the Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention Decision: Physical and Mental Functioning.
    Circulation. 2022;146:1281-1283.
    

    >> Share

    
    
93. GOLDMAN S, McCarren M, Sethi GK, Holman W, et al
    Long-Term Mortality Follow-Up of Radial Artery Versus Saphenous Vein in Coronary Artery Bypass Grafting: A Multicenter, Randomized Trial.
    Circulation. 2022;146:1323-1325.
    

    >> Share

    
    
94. GUE YX, Gorog DA, Lip GYH
    Factor XIa Inhibition: Is It a Novel Alternative Antithrombotic Strategy for High-Risk ACS Patients?
    Circulation. 2022;146:1207-1209.
    

    >> Share

    
    
95. GOUEFFIC Y, Torsello G, Zeller T, Esposito G, et al
    Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
    Circulation. 2022 Oct 18:101161CIRCULATIONAHA122059606.
    

    >> Share

    
    
96. CHENG XS, VanWagner LB, Costa SP, Axelrod DA, et al
    Emerging Evidence on Coronary Heart Disease Screening in Kidney and Liver Transplantation Candidates: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Oct 17. doi: 10.1161/CIR.0000000000001104.
    

    >> Share

    
    
97. GIANNITSIS E, Katus HA, Frey N
    Letter by Giannitsis et al Regarding Article, "Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T".
    Circulation. 2022;146:e202-e203.
    

    >> Share

    
    
98. MOISE N, Cene CW, Tabak RG, Young DR, et al
    Leveraging Implementation Science for Cardiovascular Health Equity: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Oct 10:101161CIR0000000000001096.
    

    >> Share

    
    September 2022
99. REDDY VY, Petru J, Funasako M, Kopriva K, et al
    Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation.
    Circulation. 2022 Sep 22:101161CIRCULATIONAHA122061497.
    

    >> Share

    
    
100. ZHANG Q, Burrage MK, Shanmuganathan M, Gonzales RA, et al
     Artificial Intelligence for Contrast-free MRI: Scar Assessment in Myocardial Infarction Using Deep Learning-based Virtual Native Enhancement (VNE).
     Circulation. 2022 Sep 20. doi: 10.1161/CIRCULATIONAHA.122.060137.
     

     >> Share

     
     
101. HOU L, Xie M, Zhao G
     Letter by Hou et al Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
     Circulation. 2022;146:e169.
     

     >> Share

     
     
102. DE D, Fu F, Ding M
     Letter by De et al Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
     Circulation. 2022;146:e170.
     

     >> Share

     
     
103. SONG R, Zhang L
     Response by Song and Zhang to Letters Regarding Article, "MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction".
     Circulation. 2022;146:e171-e172.
     

     >> Share

     
     
104. O'DONNELL CJ, Bradner JE
     Bridging the Gap to Translating Genome-Wide Discoveries Into Therapies to Prevent and Treat Atherosclerotic Cardiovascular Disease.
     Circulation. 2022;146:930-933.
     

     >> Share

     
     
105. AHN JM, Kang DY, Yun SC, Hur SH, et al
     Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-up Outcomes of Multicenter Randomized Controlled BEST Trial.
     Circulation. 2022 Sep 19. doi: 10.1161/CIRCULATIONAHA.122.062188.
     

     >> Share

     
     
106. BRADLEY EA, Winchester D, Alfonso CE, Carpenter AJ, et al
     Physician Wellness in Academic Cardiovascular Medicine: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Sep 19:101161CIR0000000000001093.
     

     >> Share

     
     
107. LOWRY MTH, Doudesis D, Wereski R, Kimenai DM, et al
     Influence of Age on the Diagnosis of Myocardial Infarction.
     Circulation. 2022 Sep 15:101161CIRCULATIONAHA122059994.
     

     >> Share

     
     
108. SHAH AM, Claggett B, Prasad N, Li G, et al
     Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
     Circulation. 2022 Sep 9:101161CIRCULATIONAHA122059210.
     

     >> Share

     
     
109. HADLEY MB, Henderson SB, Brauer M, Vedanthan R, et al
     Protecting Cardiovascular Health From Wildfire Smoke.
     Circulation. 2022;146:788-801.
     

     >> Share

     
     August 2022
110. BONACA MP, Morrow DA, Bergmark BA, Berg DD, et al
     Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
     Circulation. 2022 Aug 30:101161CIRCULATIONAHA122059325.
     

     >> Share

     
     
111. GARGIULO G, Giacoppo D, Jolly SS, Cairns J, et al
     Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a Meta-analysis of Individual Patient Data from Seven Multicenter Randomized Clinical Trials.
     Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061527.
     

     >> Share

     
     
112. O'DONOGHUE ML, Giugliano RP, Wiviott SD, Atar D, et al
     Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease.
     Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061620.
     

     >> Share

     
     
113. RAO SV, Kirsch B, Bhatt DL, Budaj A, et al
     A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction.
     Circulation. 2022 Aug 27. doi: 10.1161/CIRCULATIONAHA.122.061612.
     

     >> Share

     
     
114. GREENLAND P, Maron DJ, Budoff MJ
     Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients.
     Circulation. 2022;146:585-586.
     

     >> Share

     
     
115. JURGENS CY, Lee CS, Aycock DM, Masterson Creber R, et al
     State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Aug 18:101161CIR0000000000001089.
     

     >> Share

     
     
116. UDELSON JE, Selker HP, Braunwald E
     Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook.
     Circulation. 2022;146:503-505.
     

     >> Share

     
     
117. SANDOVAL Y, Apple FS, Mahler SA, Body R, et al
     High-Sensitivity Cardiac Troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guidelines for the Evaluation and Diagnosis of Acute Chest Pain.
     Circulation. 2022;146:569-581.
     

     >> Share

     
     
118. SARNAK MJ, Auguste BL, Brown E, Chang AR, et al
     Cardiovascular Effects of Home Dialysis Therapies: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Aug 15:101161CIR0000000000001088.
     

     >> Share

     
     
119. STABLES RH, Mullen LJ, Elguindy M, Nicholas Z, et al
     Routine Pressure Wire Assessment Versus Conventional Angiography in the Management of Patients With Coronary Artery Disease: The RIPCORD 2 Trial.
     Circulation. 2022 Aug 10:101161CIRCULATIONAHA121057793.
     

     >> Share

     
     
120. GELLER BJ, Sinha SS, Kapur NK, Bakitas M, et al
     Escalating and De-escalating Temporary Mechanical Circulatory Support in Cardiogenic Shock: A Scientific Statement From the American Heart Association.
     Circulation. 2022;146:e50-e68.
     

     >> Share

     
     
121. BERWANGER O, Santo K
     Cardiovascular Care in Brazil: Current Status, Challenges, and Opportunities.
     Circulation. 2022;146:435-437.
     

     >> Share

     
     July 2022
122. KHAN SS, Page C, Wojdyla DM, Schwartz YY, et al
     Predictive Utility of a Validated Polygenic Risk Score for Long-Term Risk of Coronary Heart Disease in Young and Middle-Aged Adults.
     Circulation. 2022 Jul 26:101161CIRCULATIONAHA121058426.
     

     >> Share

     
     
123. MAGNANI JW, Brewer LC
     Leaving the Social Vacuum: Expanding Cardiovascular Guidelines to Embrace Equity.
     Circulation. 2022;146:156-158.
     

     >> Share

     
     
124. KYALWAZI AN, Loccoh EC, Brewer LC, Ofili EO, et al
     Disparities in Cardiovascular Mortality Between Black and White Adults in the United States, 1999 to 2019.
     Circulation. 2022;146:211-228.
     

     >> Share

     
     
125. POST WS, Watson KE, Hansen S, Folsom AR, et al
     Racial and Ethnic Differences in All-Cause and Cardiovascular Disease Mortality: The MESA Study.
     Circulation. 2022;146:229-239.
     

     >> Share

     
     
126. BREWER LC, Jenkins S, Hayes SN, Kumbamu A, et al
     Community-Based, Cluster-Randomized Pilot Trial of a Cardiovascular Mobile Health Intervention: Preliminary Findings of the FAITH! Trial.
     Circulation. 2022;146:175-190.
     

     >> Share

     
     
127. O'SULLIVAN JW, Raghavan S, Marquez-Luna C, Luzum JA, et al
     Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Jul 18:101161CIR0000000000001077.
     

     >> Share

     
     
128. ONO M, Serruys PW, Garg S, Kawashima H, et al
     Effect of Patient-Reported Preprocedural Physical and Mental Health on 10-Year Mortality After Percutaneous or Surgical Coronary Revascularization.
     Circulation. 2022 Jul 18:101161CIRCULATIONAHA121057021.
     

     >> Share

     
     
129. NISHIYAMA C, Saito Y, Sakaguchi A, Kaneko M, et al
     Prolonged Myocardial Regenerative Capacity in Neonatal Opossum.
     Circulation. 2022;146:125-139.
     

     >> Share

     
     
130. EICHELMANN F, Sellem L, Wittenbecher C, Jager S, et al
     Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat Modulation.
     Circulation. 2022;146:21-35.
     

     >> Share

     
     June 2022
131. HAGSTROM E, Steg PG, Szarek M, Bhatt DL, et al
     Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
     Circulation. 2022 Jun 30:101161CIRCULATIONAHA121057807.
     

     >> Share

     
     
132. LLOYD-JONES DM, Ning H, Labarthe D, Brewer L, et al
     Status of Cardiovascular Health in US Adults and Children Using the American Heart Association's New "Life's Essential 8" Metrics: Prevalence Estimates from the National Health and Nutrition Examination Survey (NHANES), 2013-2018.
     Circulation. 2022 Jun 29. doi: 10.1161/CIRCULATIONAHA.122.060911.
     

     >> Share

     
     
133. LLOYD-JONES DM, Allen NB, Anderson CAM, Black T, et al
     Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association.
     Circulation. 2022 Jun 29:101161CIR0000000000001078.
     

     >> Share

     
     
134. KIMENAI DM, Pirondini L, Gregson J, Prieto D, et al
     Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular Disease.
     Circulation. 2022 Jun 24:101161CIRCULATIONAHA122060042.
     

     >> Share

     
     
135. SOLOMON CU, McVey DG, Andreadi C, Gong P, et al
     Effects of Coronary Artery Disease-Associated Variants on Vascular Smooth Muscle Cells.
     Circulation. 2022 Jun 23:101161CIRCULATIONAHA121058389.
     

     >> Share

     
     
136. KHATANA SAM, Werner RM, Groeneveld PW
     Association of Extreme Heat and Cardiovascular Mortality in the United States: A County-Level Longitudinal Analysis From 2008 to 2017.
     Circulation. 2022 Jun 21:101161CIRCULATIONAHA122060746.
     

     >> Share

     
     
137. MILLS NL, Pope CA
     Environmental Triggers of Acute Coronary Syndromes.
     Circulation. 2022;145:1761-1763.
     

     >> Share

     
     
138. 
     Correction to: Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
     Circulation. 2022 Jun 14:101161CIR0000000000001084.
     

     >> Share

     
     
139. SANDOVAL Y, Lewis BR, Mehta RA, Ola O, et al
     Rapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Evaluation.
     Circulation. 2022;145:1708-1719.
     

     >> Share

     
     
140. CHAN N, Premawardhana D, Al-Hussaini A, Wood A, et al
     Pregnancy and Spontaneous Coronary Artery Dissection: Lessons From Survivors and Nonsurvivors.
     Circulation. 2022 Jun 3. doi: 10.1161/CIRCULATIONAHA.122.059635.
     

     >> Share

     
     
141. ZHENG Y, Joyce B, Hwang SJ, Ma J, et al
     Association of Cardiovascular Health Through Young Adulthood With Genome-Wide DNA Methylation Patterns in Midlife: The CARDIA Study.
     Circulation. 2022 Jun 2:101161CIRCULATIONAHA121055484.
     

     >> Share

     
     May 2022
142. FEARON WF, Zimmermann FM, Ding VY, Zelis JM, et al
     Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
     Circulation. 2022;145:1655-1662.
     

     >> Share

     
     
143. ANTHONY C, Imran M, Pouliopoulos J, Emmanuel S, et al
     Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation.
     Circulation. 2022 May 27:101161CIRCULATIONAHA121057006.
     

     >> Share

     
     
144. SHAH NS, Ning H, Petito LC, Kershaw KN, et al
     Associations of Clinical and Social Risk Factors With Racial Differences in Premature Cardiovascular Disease.
     Circulation. 2022 May 24:101161CIRCULATIONAHA121058311.
     

     >> Share

     
     
145. GOLDBERG RB, Orchard TJ, Crandall JP, Boyko EJ, et al
     Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.
     Circulation. 2022 May 23. doi: 10.1161/CIRCULATIONAHA.121.056756.
     

     >> Share

     
     
146. 
     Correction to: Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
     Circulation. 2022 May 20:101161CIR0000000000001080.
     

     >> Share

     
     
147. PETEK BJ, Moulson N, Drezner JA, Harmon KG, et al
     Cardiovascular Outcomes in Collegiate Athletes Following SARS-CoV-2 Infection: 1-year Follow-up from the Outcomes Registry for Cardiac Conditions in Athletes.
     Circulation. 2022 May 12. doi: 10.1161/CIRCULATIONAHA.121.058272.
     

     >> Share

     
     
148. CHOW CK, Klimis H, Thiagalingam A, Redfern J, et al
     Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical Trial.
     Circulation. 2022;145:1443-1455.
     

     >> Share

     
     
149. NAGAREDDY PR, Sreejit G
     Response by Nagareddy and Sreejit to Letter Regarding Article, "Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis".
     Circulation. 2022;145:e1035-e1036.
     

     >> Share

     
     
150. REN C, Yang Z
     Letter by Ren and Yang Regarding Article, "Retention of the NLRP3 Inflammasome-Primed Neutrophils in the Bone Marrow Is Essential for Myocardial Infarction-Induced Granulopoiesis".
     Circulation. 2022;145:e1034.
     

     >> Share

     
     
151. WENGER NK, Lloyd-Jones DM, Elkind MSV, Fonarow GC, et al
     Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association.
     Circulation. 2022 May 9:101161CIR0000000000001071.
     

     >> Share

     
     
152. BERLOWITZ JB, Xie W, Harlow AF, Hamburg NM, et al
     E-cigarette Use and Risk of Cardiovascular Disease: A Longitudinal Analysis of the PATH Study, 2013-2019.
     Circulation. 2022 May 6. doi: 10.1161/CIRCULATIONAHA.121.057369.
     

     >> Share

     
     
153. FURTADO RHM, Raz I, Goodrich EL, Murphy SA, et al
     Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
     Circulation. 2022 May 5. doi: 10.1161/CIRCULATIONAHA.121.058103.
     

     >> Share

     
     
154. EMOTO T, Yamamoto H, Yamashita T, Takaya T, et al
     Single-Cell RNA Sequencing Reveals a Distinct Immune Landscape of Myeloid Cells in Coronary Culprit Plaques Causing Acute Coronary Syndrome.
     Circulation. 2022;145:1434-1436.
     

     >> Share

     
     April 2022
155. PATEL KK
     Improving Symptoms and Quality of Life in Stable Coronary Artery Disease: An Evolving Paradigm.
     Circulation. 2022;145:1308-1311.
     

     >> Share

     
     
156. BOUCHARD K, Liu PP, Tulloch H
     The Social Robots Are Coming: Preparing for a New Wave of Virtual Care in Cardiovascular Medicine.
     Circulation. 2022;145:1291-1293.
     

     >> Share

     
     
157. CHEN R, Jiang Y, Hu J, Chen H, et al
     Hourly Air Pollutants and Acute Coronary Syndrome Onset In 1.29 Million Patients.
     Circulation. 2022 Apr 22. doi: 10.1161/CIRCULATIONAHA.121.057179.
     

     >> Share

     
     
158. 
     Correction to: Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
     Circulation. 2022;145:e841.
     

     >> Share

     
     
159. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
     Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
     Circulation. 2022;145:1254-1284.
     

     >> Share

     
     
160. WHITE HD
     Zooming in on the Enigmas of Type 2 Myocardial Infarction.
     Circulation. 2022;145:1201-1204.
     

     >> Share

     
     
161. JIA D, Chen S, Bai P, Luo C, et al
     Cardiac Resident Macrophage-derived Legumain Improves Cardiac Repair via Promoting Clearance and Degradation of Apoptotic Cardiomyocytes after Myocardial Infarction.
     Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057549.
     

     >> Share

     
     
162. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
     Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
     Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
     

     >> Share

     
     
163. ZHANG J, Liang R, Wang K, Zhang W, et al
     Novel CaMKII-delta Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.
     Circulation. 2022;145:1154-1168.
     

     >> Share

     
     
164. JONE PN, John A, Oster ME, Allen K, et al
     SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Apr 11:101161CIR0000000000001064.
     

     >> Share

     
     March 2022
165. SINGH T, Khan H, Gamble DT, Scally C, et al
     Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications.
     Circulation. 2022;145:1002-1019.
     

     >> Share

     
     
166. KUEHN BM
     Higher Risk of Heart Disease Among South Asians Calls for Targeted Interventions.
     Circulation. 2022;145:1020-1021.
     

     >> Share

     
     
167. BULARGA A, Hung J, Daghem M, Stewart S, et al
     Coronary Artery and Cardiac Disease in Patients With Type 2 Myocardial Infarction: A Prospective Cohort Study.
     Circulation. 2022 Mar 28. doi: 10.1161/CIRCULATIONAHA.121.058542.
     

     >> Share

     
     
168. 
     Correction to: Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
     Circulation. 2022;145:e775.
     

     >> Share

     
     
169. NG CF, Teoh JYC, Chiu PKF
     Letter by Ng et al Regarding Article, "Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial".
     Circulation. 2022;145:e773-e774.
     

     >> Share

     
     
170. SONG R, Dasgupta C, Mulder C, Zhang L, et al
     MicroRNA-210 Controls Mitochondrial Metabolism and Protects Heart Function in Myocardial Infarction.
     Circulation. 2022 Mar 17. doi: 10.1161/CIRCULATIONAHA.121.056929.
     

     >> Share

     
     
171. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2022;145:e772.
     

     >> Share

     
     
172. 
     Correction to: 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2022;145:e771.
     

     >> Share

     
     
173. MARK DB, Spertus JA, Bigelow R, Anderson S, et al
     Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
     Circulation. 2022 Mar 9. doi: 10.1161/CIRCULATIONAHA.121.057363.
     

     >> Share

     
     
174. NAGAREDDY PR, Sreejit G
     Letter by Nagareddy and Sreejit Regarding Article, "Interleukin-1alpha Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease".
     Circulation. 2022;145:e762-e763.
     

     >> Share

     
     
175. SCHUNK SJ, Speer T
     Response by Schunk and Speer to the Letter Regarding Article, "Interleukin-1alpha Is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease".
     Circulation. 2022;145:e764.
     

     >> Share

     
     
176. MAAMARI DJ, Jaffer FA, Khera AV, Fahed AC, et al
     CYP2C19 Genotyping in Anticoagulated Patients After Percutaneous Coronary Intervention: Should It Be Routine?
     Circulation. 2022;145:721-723.
     

     >> Share

     
     
177. FENG G, Bajpai G, Ma P, Koenig A, et al
     CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
     Circulation. 2022;145:765-782.
     

     >> Share

     
     
178. KOHLI-LYNCH CN, Lewsey J, Boyd KA, French DD, et al
     Beyond Ten-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.
     Circulation. 2022 Mar 7. doi: 10.1161/CIRCULATIONAHA.121.057631.
     

     >> Share

     
     
179. 
     Correction to: 2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implem
     Circulation. 2022;145:e760.
     

     >> Share

     
     
180. LAWLER PR, Hochman JS, Zarychanski R
     What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine?
     Circulation. 2022;145:629-632.
     

     >> Share

     
     February 2022
181. OPSTAL TSJ, van Broekhoven A, Fiolet ATL, Mosterd A, et al
     Long-Term Efficacy of Colchicine in Patients With Chronic Coronary Disease: Insights From LoDoCo2.
     Circulation. 2022;145:626-628.
     

     >> Share

     
     
182. INDOLFI C, Esposito G
     Universal Health Care System and Cardiovascular Disease Burden in Italy.
     Circulation. 2022;145:559-561.
     

     >> Share

     
     
183. LAM CSP
     How to Incorporate Sex and Gender Into the Design of Cardiovascular Clinical Trials.
     Circulation. 2022;145:499-501.
     

     >> Share

     
     
184. ANDROULAKIS E, Azzu A, Papagkikas P, Antonopoulos A, et al
     Spontaneous Coronary Artery Dissection: Insights From Cardiac Magnetic Resonance and Extracoronary Arterial Screening.
     Circulation. 2022;145:555-557.
     

     >> Share

     
     
185. LINDLEY KJ
     Call for Action to Address Increasing Maternal Cardiovascular Mortality in the United States: Strategies for Improving Maternal Cardiovascular Care.
     Circulation. 2022;145:502-504.
     

     >> Share

     
     
186. GONZALEZ-JUANATEY JR, Lemesle G, Puymirat E, Ducrocq G, et al
     One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial.
     Circulation. 2022;145:486-488.
     

     >> Share

     
     
187. MESSERLI FH, Bavishi C, Bangalore S
     Why Are We Still Prescribing Angiotensin-Converting Enzyme Inhibitors?
     Circulation. 2022;145:413-415.
     

     >> Share

     
     
188. GAO P, You M, Li L, Zhang Q, et al
     Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3.
     Circulation. 2022;145:375-391.
     

     >> Share

     
     
189. LLOYD-JONES DM
     The Power of Patient Stories to Inspire Us to Prevent Cardiovascular Disease and Death: Personal Reflections on the AHA's Scientific Sessions 2021.
     Circulation. 2022;145:e143-e145.
     

     >> Share

     
     
190. ENAS EA, Varkey B
     Letter by Enas and Varkey Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
     Circulation. 2022;145:e146.
     

     >> Share

     
     
191. PATEL AP, Khera AV
     Response by Patel and Khera to Letter Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
     Circulation. 2022;145:e147-e148.
     

     >> Share

     
     January 2022
192. HASBANI NR, Ligthart S, Brown MR, Heath AS, et al
     American Heart Association's Life's Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease.
     Circulation. 2022 Jan 31. doi: 10.1161/CIRCULATIONAHA.121.053730.
     

     >> Share

     
     
193. ABOULEISA RRE, Salama ABM, Ou Q, Tang XL, et al
     Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure.
     Circulation. 2022 Jan 21. doi: 10.1161/CIRCULATIONAHA.121.057641.
     

     >> Share

     
     
194. CHEW DS, Cowper PA, Al-Khalidi H, Anstrom KJ, et al
     Cost Effectiveness of Coronary-Artery Bypass Surgery versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial.
     Circulation. 2022 Jan 19. doi: 10.1161/CIRCULATIONAHA.121.056276.
     

     >> Share

     
     
195. GRUBB KJ, Kirtane AJ
     The Long-Awaited Revascularization Guidelines Are Out: What's In Them?
     Circulation. 2022;145:155-157.
     

     >> Share

     
     
196. DE LEMOS JA, McGuire DK, Hill JA
     Celebrating The Next Generation of Cardiovascular Investigators.
     Circulation. 2022;145:91-93.
     

     >> Share

     
     
197. JOSEPH JJ, Deedwania P, Acharya T, Aguilar D, et al
     Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association.
     Circulation. 2022 Jan 10:CIR0000000000001040. doi: 10.1161/CIR.0000000000001040.
     

     >> Share

     
     
198. DEFTEREOS SG, Beerkens FJ, Shah B, Giannopoulos G, et al
     Colchicine in Cardiovascular Disease: In-Depth Review.
     Circulation. 2022;145:61-78.
     

     >> Share

     
     
199. CHURCHWELL K, Lloyd-Jones DM, Rochat Harris S, Mehta LS, et al
     Policy Change Needed to Improve Maternal Cardiovascular Health.
     Circulation. 2022;145:e1-e3.
     

     >> Share

     
     December 2021
200. KUEHN BM
     Centering Equity in Cardiovascular Care.
     Circulation. 2021;144:2035-2037.
     

     >> Share

     
     
201. LI C, Qu L, Matz AJ, Murphy PA, et al
     AtheroSpectrum Reveals Novel Macrophage Foam Cell gene Signatures Associated with Atherosclerotic Cardiovascular Disease Risk.
     Circulation. 2021 Dec 16. doi: 10.1161/CIRCULATIONAHA.121.054285.
     

     >> Share

     
     
202. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
     2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2021 Dec 9:CIR0000000000001039. doi: 10.1161/CIR.0000000000001039.
     

     >> Share

     
     
203. LAWTON JS, Tamis-Holland JE, Bangalore S, Bates ER, et al
     2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
     Circulation. 2021 Dec 9:CIR0000000000001038. doi: 10.1161/CIR.0000000000001038.
     

     >> Share

     
     
204. AL RIFAI M, Blaha MJ, Nambi V, Shea SJC, et al
     Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis.
     Circulation. 2021 Dec 8. doi: 10.1161/CIRCULATIONAHA.121.056705.
     

     >> Share

     
     
205. CHANG Q, Xu Z, Liu R
     Acute Inferior Wall Myocardial Infarction: What Is the Culprit Artery?
     Circulation. 2021;144:1893-1895.
     

     >> Share

     
     
206. LAMBRAKIS K, Chew DP
     Response by Lambrakis and Chew to Letter Regarding Article, "Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS".
     Circulation. 2021;144:e459-e460.
     

     >> Share

     
     
207. CHIANG CH, Chiang CH, Lee CC
     Letter by Chiang et al Regarding Article, "Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS".
     Circulation. 2021;144:e457-e458.
     

     >> Share

     
     November 2021
208. KATZ DH, Tahir UA, Bick AG, Pampana A, et al
     Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights into Cardiovascular Disease.
     Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.055117.
     

     >> Share

     
     
209. SREEJIT G, Nooti SK, Jaggers RM, Athmanathan B, et al
     Retention of the NLRP3 Inflammasome-primed Neutrophils in the Bone Marrow is Essential for Myocardial Infarction-induced Granulopoiesis.
     Circulation. 2021 Nov 17. doi: 10.1161/CIRCULATIONAHA.121.056019.
     

     >> Share

     
     
210. RAMAN B, Tunnicliffe EM, Chan K, Ariga R, et al
     Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
     Circulation. 2021;144:1656-1658.
     

     >> Share

     
     
211. LAI Y, Zhuang X, Liao X
     Letter by Lai et al Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
     Circulation. 2021;144:e307.
     

     >> Share

     
     
212. HAKALA JO, Raitakari OT, Rovio SP
     Response by Hakala et al to Letter Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study".
     Circulation. 2021;144:e308-e309.
     

     >> Share

     
     
213. WYCKOFF MH, Singletary EM, Soar J, Olasveengen TM, et al
     2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and T
     Circulation. 2021 Nov 11:CIR0000000000001017. doi: 10.1161/CIR.0000000000001017.
     

     >> Share

     
     
214. ZAHA VG, Hayek SS, Alexander KM, Beckie TM, et al
     Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Nov 10:CIR0000000000001032. doi: 10.1161/CIR.0000000000001032.
     

     >> Share

     
     
215. 
     Correction to: Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
     Circulation. 2021;144:e306.
     

     >> Share

     
     
216. TONG DC, Bloom JE, Quinn S, Nasis A, et al
     Colchicine in Patients With Acute Coronary Syndrome: Two-Year Follow-Up of the Australian COPS Randomized Clinical Trial.
     Circulation. 2021;144:1584-1586.
     

     >> Share

     
     
217. SCHAEFER I, Lopez-Ayala P, Mueller C
     Letter by Schaefer et al Regarding Article, "Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort".
     Circulation. 2021;144:e283-e284.
     

     >> Share

     
     
218. ALLEN BR, Christenson RH, Cohen SA, Weaver MT, et al
     Response by Allen et al to Letter Regarding Article, "Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort".
     Circulation. 2021;144:e285-e286.
     

     >> Share

     
     
219. AUER R, Diethelm P, Berthet A
     Heating Tobacco Sticks Instead of Combusting Conventional Cigarettes and Future Heart Attacks: Still Smoke, and Risk.
     Circulation. 2021;144:1539-1542.
     

     >> Share

     
     
220. RUETZLER K, Smilowitz NR, Berger JS, Devereaux PJ, et al
     Diagnosis and Management of Patients With Myocardial Injury After Noncardiac Surgery: A Scientific Statement From the American Heart Association.
     Circulation. 2021;144:e287-e305.
     

     >> Share

     
     
221. LADDU D, Ma J, Kaar J, Ozemek C, et al
     Health Behavior Change Programs in Primary Care and Community Practices for Cardiovascular Disease Prevention and Risk Factor Management Among Midlife and Older Adults: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Nov 4:CIR0000000000001026. doi: 10.1161/CIR.0000000000001026.
     

     >> Share

     
     
222. MICHOS ED, Udell JA
     Am I Getting the Influenza Shot Too?: Influenza Vaccination as Post-Myocardial Infarction Care for the Prevention of Cardiovascular Events and Death.
     Circulation. 2021;144:1485-1488.
     

     >> Share

     
     
223. CHUANG YT, Ueng KC, Tsai CF
     Grouped Beating After Acute Inferior Myocardial Infarction.
     Circulation. 2021;144:1518-1520.
     

     >> Share

     
     
224. LICHTENSTEIN AH, Appel LJ, Vadiveloo M, Hu FB, et al
     2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
     Circulation. 2021 Nov 2:CIR0000000000001031. doi: 10.1161/CIR.0000000000001031.
     

     >> Share

     
     
225. COWIE MR, Deanfield J
     Cardiovascular Medicine at a Crossroads in the United Kingdom.
     Circulation. 2021;144:1457-1458.
     

     >> Share

     
     
226. MCNALLY EM, Elkind MSV, Benjamin IJ, Chung MK, et al
     Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association.
     Circulation. 2021 Nov 1:CIR0000000000001027. doi: 10.1161/CIR.0000000000001027.
     

     >> Share

     
     October 2021
227. VERMA S, Bhatt DL, Steg PG, Miller M, et al
     Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
     Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
     

     >> Share

     
     
228. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
     Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
     Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
     

     >> Share

     
     
229. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
     Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
     Circulation. 2021;144:1449-1451.
     

     >> Share

     
     
230. BRAILLON A
     Letter by Braillon Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
     Circulation. 2021;144:e274.
     

     >> Share

     
     
231. PENG AW, Dardari ZA, Blaha MJ
     Response by Peng et al to Letter Regarding Article, "Very High Coronary Artery Calcium (>/=1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA".
     Circulation. 2021;144:e275-e276.
     

     >> Share

     
     
232. NEELAND IJ, McGuire DK, Sattar N
     Cardiovascular Outcomes Trials for Weight Loss Interventions: Another Tool for Cardiovascular Prevention?
     Circulation. 2021;144:1359-1361.
     

     >> Share

     
     
233. SANCHEZ-LOPEZ A, Espinos-Estevez C, Gonzalez-Gomez C, Gonzalo P, et al
     Cardiovascular Progerin Suppression and lamin A Restoration Rescues Hutchinson-Gilford Progeria Syndrome.
     Circulation. 2021 Oct 25. doi: 10.1161/CIRCULATIONAHA.121.055313.
     

     >> Share

     
     
234. KRIS-ETHERTON PM, Petersen KS, Despres JP, Anderson CAM, et al
     Strategies for Promotion of a Healthy Lifestyle in Clinical Settings: Pillars of Ideal Cardiovascular Health: A Science Advisory From the American Heart Association.
     Circulation. 2021 Oct 25:CIR0000000000001018. doi: 10.1161/CIR.0000000000001018.
     

     >> Share

     
     
235. ALE-AGHA N, Jakobs P, Goy C, Zurek M, et al
     Mitochondrial Telomerase Reverse Transcriptase Protects from Myocardial Ischemia/reperfusion Injury by Improving Complex I Composition and Function.
     Circulation. 2021 Oct 21. doi: 10.1161/CIRCULATIONAHA.120.051923.
     

     >> Share

     
     
236. 
     Correction to: Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial.
     Circulation. 2021;144:e273.
     

     >> Share

     
     
237. KHAN SU, Javed Z, Lone AN, Dani SS, et al
     Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
     Circulation. 2021;144:1272-1279.
     

     >> Share

     
     
238. GANGAVELLI A, Morris AA
     Premature Cardiovascular Mortality in the United States: Who Will Protect the Most Vulnerable Among Us?
     Circulation. 2021;144:1280-1283.
     

     >> Share

     
     
239. JACOBS AK, Ali MJ, Best PJ, Bieniarz MC, et al
     Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart Association.
     Circulation. 2021 Oct 13:CIR0000000000001025. doi: 10.1161/CIR.0000000000001025.
     

     >> Share

     
     
240. LEE LY, Oldham WM, He H, Wang R, et al
     Interferon-gamma Impairs Human Coronary Artery Endothelial Glucose Metabolism via Tryptophan Catabolism and Activates Fatty Acid Oxidation.
     Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.053960.
     

     >> Share

     
     
241. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
     Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
     Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
     

     >> Share

     
     
242. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
     The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
     Circulation. 2021;144:1160-1171.
     

     >> Share

     
     
243. RUEL M, Fischbein M
     Introduction to the 2021 Cardiovascular Surgery Themed Issue of Circulation.
     Circulation. 2021;144:1087.
     

     >> Share

     
     
244. CHOI S, Lee K, Park SM
     Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
     Circulation. 2021 Oct 4. doi: 10.1161/CIRCULATIONAHA.121.054967.
     

     >> Share

     
     September 2021
245. KEN LEE K, Wereski R, Williams MC, Mills NL, et al
     Population Screening With Coronary Computed Tomography Angiography and the Prevention of Coronary Events.
     Circulation. 2021;144:930-933.
     

     >> Share

     
     
246. REDD MA, Scheuer SE, Saez NJ, Yoshikawa Y, et al
     Therapeutic Inhibition of Acid-Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
     Circulation. 2021;144:947-960.
     

     >> Share

     
     
247. LOPEZ-AYALA P, Nestelberger T, Boeddinghaus J, Koechlin L, et al
     Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm.
     Circulation. 2021;144:773-787.
     

     >> Share

     
     August 2021
248. XENOGIANNIS I, Zenati M, Bhatt DL, Rao SV, et al
     Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
     Circulation. 2021;144:728-745.
     

     >> Share

     
     
249. RAJENDRAN G, Muthanikkatt AM, Nathan B
     Not All Waves Are Factual.
     Circulation. 2021;144:751-753.
     

     >> Share

     
     
250. WATERS DD, Stone GW
     Usefulness of Angina to Guide Revascularization Decisions.
     Circulation. 2021;144:524-527.
     

     >> Share

     
     
251. MESNIER J, Ducrocq G, Danchin N, Ferrari R, et al
     International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study.
     Circulation. 2021;144:512-523.
     

     >> Share

     
     
252. GOLDSTEIN LN, Wu MT, Wells M
     Does This Ischemic Pattern Look Right?
     Circulation. 2021;144:499-501.
     

     >> Share

     
     
253. SANKARDAS MA, Ramakumar V, Farooqui FA
     Of Occlusions, Inclusions, and Exclusions: Time to Reclassify Infarctions?
     Circulation. 2021;144:333-335.
     

     >> Share

     
     July 2021
254. REAL C, Morales T, Viana-Tejedor A
     An Unusual Call From the Urology Ward.
     Circulation. 2021;144:324-327.
     

     >> Share

     
     
255. SRIDHARAN A, Han JK, Feliciano Z
     An Ominous ECG.
     Circulation. 2021;144:246-248.
     

     >> Share

     
     
256. LAMBRAKIS K, Papendick C, French JK, Quinn S, et al
     Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS.
     Circulation. 2021;144:113-125.
     

     >> Share

     
     June 2021
257. MEUWESE CL, Kraaijeveld AO, Donker DW
     Letter by Meuwese et al Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Coho
     Circulation. 2021;143:e1022-e1023.
     

     >> Share

     
     
258. SCHRAGE B, Westermann D
     Response by Schrage and Westermann to Letters Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an Internati
     Circulation. 2021;143:e1024.
     

     >> Share

     
     
259. MEHMOOD M
     Letter by Mehmood Regarding Article, "Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Stu
     Circulation. 2021;143:e1021.
     

     >> Share

     
     
260. EDELMAN ER
     Karnovsky's Dictum: The Endothelium Is Good-Looking and Smart.
     Circulation. 2021;143:2166-2168.
     

     >> Share

     
     May 2021
261. ISOMI M, Sadahiro T, Yamakawa H, Fujita R, et al
     Overexpression of Gata4, Mef2c, and Tbx5 Generates Induced Cardiomyocytes Via Direct Reprogramming and Rare Fusion in the Heart.
     Circulation. 2021;143:2123-2125.
     

     >> Share

     
     March 2021
262. CHUZI S, Kuang F, Khan SS
     Hidden in Plain Sight: An Elusive Cause of Cardiogenic Shock.
     Circulation. 2021;143:959-964.
     

     >> Share

     
     February 2021
263. FORTE E, Perkins B, Sintou A, Kalkat HS, et al
     Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart.
     Circulation. 2021;143:821-836.
     

     >> Share

     
     
264. KARABINOS I, Kostaki P, Panagopoulos Z
     Bizarre Downsloping ST Segment Elevation Challenge.
     Circulation. 2021;143:599-601.
     

     >> Share

     
     January 2021
265. BHASIN D, Isser HS, Gupta A
     Chest Pain With ST-Segment Elevation in a Young Woman: A Broken Heart?
     Circulation. 2021;143:197-201.
     

     >> Share

     
     
266. RASANEN M, Sultan I, Paech J, Hemanthakumar KA, et al
     VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration.
     Circulation. 2021;143:65-77.
     

     >> Share

     
     
267. QI Z, Hu L, Zhang J, Yang W, et al
     PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
     Circulation. 2021;143:45-61.
     

     >> Share

     
     November 2020
268. REYNOLDS HR, Maehara A, Kwong RY, Sedlak T, et al
     Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of MINOCA in Women.
     Circulation. 2020 Nov 14. doi: 10.1161/CIRCULATIONAHA.120.052008.
     

     >> Share

     
     August 2020
269. LOPES RD, Alexander KP, Stevens SR, Reynolds HR, et al
     Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
     Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050304.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share